This inventor holds 32 USPTO granted patents and 3 EPO patents. Top assignees: Baxter International Inc., Baxter Healthcare Sa. Active years: 2001-2025.
Location History:
- Vernoon Hills, IL (US) (2006)
- Vernon Hills, IL (US) (2001 - 2021)
Company Filing History:
32 out of 2,530 
7 out of 1,198 Years Active: 2001-2025
Areas of Expertise:
Title: **Michael T K Ling: Innovator in Nanoclay Sorbent Technologies**
Introduction
Michael T K Ling, an accomplished inventor based in Vernon Hills, IL, boasts an impressive portfolio of 31 patents. His contributions to the field of dialysis through innovative nanoclay sorbent technologies promise to revolutionize how waste products are absorbed from the body, improving the lives of patients requiring this essential treatment.
Latest Patents
Among his latest patents, Ling has developed novel methods using nanoclay sorbents for dialysis. These sorbents, which include montmorillonite, bentonite, and other clays, demonstrate a significant ability to absorb body wastes such as ammonium, phosphate, and creatinine more effectively than conventional sorbents. His designs incorporate wearable systems that circulate dialysis fluid through filters containing these nanoclay sorbents. This innovative approach not only absorbs waste products but also recycles the dialysis fluid back into a patient’s peritoneum. Further enhancing their utility, these materials utilize ion-exchange capabilities to replace waste ions with beneficial ones like calcium, magnesium, and bicarbonate, thus refreshing the dialysis fluid used in hemodialysis and minimizing the fluid quantity needed for treatment.
Career Highlights
Michael Ling's career includes significant contributions while working at Baxter International Inc. and Baxter Healthcare SA. His dedication to enhancing dialysis processes through innovative materials illustrates his commitment to advancing medical technology.
Collaborations
During his career, Ling has collaborated with notable individuals, including Lecon Woo and Yuan-pang Samuel Ding. These partnerships have likely fostered an environment of creativity and innovation, driving progress in the development of groundbreaking dialysis treatments.
Conclusion
Michael T K Ling stands as a prominent figure in the realm of clinical innovations, particularly through his pioneering work with nanoclay sorbents. With his extensive experience and numerous patents, Ling continues to push the boundaries of healthcare technology, contributing significantly to the improvement of patient care in dialysis.